Pharmadax Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 113.156 million compared to TWD 17.720 million a year ago. Operating loss was TWD 155.754 million compared to TWD 226.951 million a year ago. Net loss was TWD 158.879 million compared to TWD 215.812 million a year ago. Basic loss per share was TWD 2.63 compared to TWD 3.77 a year ago.